Cargando…

Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo

MIR143 is pathologically downregulated and may function as a tumor suppressor in prostate cancer. Likewise, the urokinase plasminogen activator receptor (UPAR) is overexpressed in prostate carcinoma, representing a negative prognostic marker and putative therapeutic target gene. In this paper, we es...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wach, Sven, Brandl, Madeleine, Borchardt, Hannes, Weigelt, Katrin, Lukat, Sabine, Nolte, Elke, Al-Janabi, Omar, Hart, Martin, Grässer, Friedrich, Giedl, Johannes, Jung, Rudolf, Stöhr, Robert, Hartmann, Arndt, Lieb, Verena, Höbel, Sabrina, Peters, Anna, Stäubert, Claudia, Wullich, Bernd, Taubert, Helge, Aigner, Achim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444223/ https://www.ncbi.nlm.nih.gov/pubmed/30933831 http://dx.doi.org/10.1016/j.omtn.2019.02.020

Ejemplares similares

Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma
por: Bellut, Julia, et al.
Publicado: (2017)

Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
por: Eckstein, Markus, et al.
Publicado: (2018)

Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients
por: Lieb, Verena, et al.
Publicado: (2021)

Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients
por: Lieb, Verena, et al.
Publicado: (2022)

Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients
por: Abdulrahman, Amer, et al.
Publicado: (2019)

Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients
por: König, Paul, et al.
Publicado: (2020)

CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
por: Eckstein, Markus, et al.
Publicado: (2020)

Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy
por: Taubert, Helge, et al.
Publicado: (2021)

Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients
por: Eckstein, Markus, et al.
Publicado: (2021)

Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients
por: Fichte, Alexander, et al.
Publicado: (2022)

Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
por: Kahlmeyer, Andreas, et al.
Publicado: (2019)

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis
por: Sikic, Danijel, et al.
Publicado: (2017)

Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder Tumors
por: Marquardt, Alexander, et al.
Publicado: (2022)

RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes
por: Wach, Sven, et al.
Publicado: (2019)

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma
por: Kunz, Manfred, et al.
Publicado: (2020)

A new semisynthetic cardenolide analog 3β-[2-(1-amantadine)- 1-on-ethylamine]-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines
por: Nolte, Elke, et al.
Publicado: (2017)

Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study
por: Rogler, Anja, et al.
Publicado: (2014)

MicroRNA profiles classify papillary renal cell carcinoma subtypes
por: Wach, S, et al.
Publicado: (2013)

Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients
por: Stöhr, Christine G., et al.
Publicado: (2019)

TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers
por: Weyerer, Veronika, et al.
Publicado: (2021)

Endogenous Retroviral–K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell Carcinoma
por: Weyerer, Veronika, et al.
Publicado: (2021)

Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes
por: Szczyrba, Jaroslaw, et al.
Publicado: (2017)

Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis
por: Kubon, Jennifer, et al.
Publicado: (2020)

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
por: Greither, Thomas, et al.
Publicado: (2018)

Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
por: Krumbholz, Manuela, et al.
Publicado: (2019)

Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
por: Keck, Bastian, et al.
Publicado: (2013)

Association of Tissue mRNA and Serum Antigen Levels of Members of the Urokinase-Type Plasminogen Activator System with Clinical and Prognostic Parameters in Prostate Cancer
por: Al-Janabi, Omar, et al.
Publicado: (2014)

HLA-E expression and its clinical relevance in human renal cell carcinoma
por: Seliger, Barbara, et al.
Publicado: (2016)

Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients
por: Lieb, Verena, et al.
Publicado: (2017)

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort
por: Weyerer, Veronika, et al.
Publicado: (2021)

Risk Factor Analysis for Long-Term Graft Survival Following Pediatric Kidney Transplantation: The Importance of Pretransplantation Time on Dialysis and Donor/Recipient Age Difference
por: Marcou, Marios, et al.
Publicado: (2023)

Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients
por: Stoehr, C G, et al.
Publicado: (2016)

Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma
por: Schulze, Daniel, et al.
Publicado: (2011)

High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma
por: Feiersinger, Fabian, et al.
Publicado: (2016)

CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma
por: Friedrich, Michael, et al.
Publicado: (2020)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
por: Simon, Adrian Georg, et al.
Publicado: (2020)

The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dl03tp878va842r3enkrn7a65e